  | [ Sticky ] Round 1 Forum Member Prioritization - | 42 | 46,804 |
Replies
42
Views
46,804
|
3/28/2015 5:00:43 AM
by DeeBee  |
| [ Sticky ] Round 1 Forum Member Prioritization |
| Replies: 42 Views: 46,804 |
Latest: 3/28/2015 5:00:43 AM
by DeeBee |
| [ Sticky ] Forum’s Choice Program at ALS TDI | 2 | 19,453 |
Replies
2
Views
19,453
|
3/13/2008 9:55:40 AM
by jmccarty |
| [ Sticky ] Forum’s Choice Program at ALS TDI |
| Replies: 2 Views: 19,453 |
Latest: 3/13/2008 9:55:40 AM
by jmccarty |
  | Is Amyotrophic Lateral Sclerosis, (ALS), like chocolate cake? - | 27 | 5,607 |
Replies
27
Views
5,607
|
12/10/2018 3:26:51 AM
by David Hicks |
| Is Amyotrophic Lateral Sclerosis, (ALS), like chocolate cake? |
| Replies: 27 Views: 5,607 |
Latest: 12/10/2018 3:26:51 AM
by David Hicks |
| METFORMIN - | 220 | 152,563 |
Replies
220
Views
152,563
|
10/10/2018 1:34:40 PM
by Mau |
| METFORMIN |
| Replies: 220 Views: 152,563 |
Latest: 10/10/2018 1:34:40 PM
by Mau |
| Lignite extract to restore tight junctions in the gut, BBB, and NMJ | 1 | 1,037 |
Replies
1
Views
1,037
|
9/28/2018 12:08:30 AM
by royalfig |
| Lignite extract to restore tight junctions in the gut, BBB, and NMJ |
| Replies: 1 Views: 1,037 |
Latest: 9/28/2018 12:08:30 AM
by royalfig |
| I nominate Olaratumab to be re-purposed for sporadic ALS. | 0 | 679 |
Replies
0
Views
679
|
9/8/2018 3:16:52 AM
by David Hicks |
| I nominate Olaratumab to be re-purposed for sporadic ALS. |
| Replies: 0 Views: 679 |
Latest: 9/8/2018 3:16:52 AM
by David Hicks |
| TUDCA - | 38 | 31,312 |
Replies
38
Views
31,312
|
3/18/2018 4:14:25 PM
by Dalerfink |
| TUDCA |
| Replies: 38 Views: 31,312 |
Latest: 3/18/2018 4:14:25 PM
by Dalerfink |
| I nominate Elysium i.e. Nicotinamide riboside and pterostilbene for immediate testing in mouse models | 1 | 4,145 |
Replies
1
Views
4,145
|
12/11/2017 6:02:38 PM
by shueydj |
| I nominate Elysium i.e. Nicotinamide riboside and pterostilbene for immediate testing in mouse models |
| Replies: 1 Views: 4,145 |
Latest: 12/11/2017 6:02:38 PM
by shueydj |
| PARP-1 references and my blog | 5 | 7,193 |
Replies
5
Views
7,193
|
11/20/2017 10:08:43 PM
by shueydj |
| PARP-1 references and my blog |
| Replies: 5 Views: 7,193 |
Latest: 11/20/2017 10:08:43 PM
by shueydj |
| ATN-224 - Choline tetrathiomolybdate - | 93 | 76,329 |
Replies
93
Views
76,329
|
2/10/2017 5:13:19 PM
by Mary Reid |
| ATN-224 - Choline tetrathiomolybdate |
| Replies: 93 Views: 76,329 |
Latest: 2/10/2017 5:13:19 PM
by Mary Reid |
| MYRIOCIN, GW4869 AND NAC - | 32 | 7,640 |
Replies
32
Views
7,640
|
2/4/2017 3:58:27 PM
by Mary Reid |
| MYRIOCIN, GW4869 AND NAC |
| Replies: 32 Views: 7,640 |
Latest: 2/4/2017 3:58:27 PM
by Mary Reid |
| Soliris - Eculizumab | 3 | 6,915 |
Replies
3
Views
6,915
|
1/28/2017 6:41:43 AM
by Mary Reid |
| Soliris - Eculizumab |
| Replies: 3 Views: 6,915 |
Latest: 1/28/2017 6:41:43 AM
by Mary Reid |
| Detailed rationale for testing PARP-1 inhibitors | 12 | 7,292 |
Replies
12
Views
7,292
|
10/21/2016 7:55:01 PM
by Mary Reid |
| Detailed rationale for testing PARP-1 inhibitors |
| Replies: 12 Views: 7,292 |
Latest: 10/21/2016 7:55:01 PM
by Mary Reid |
| Another suitable PARP-1 inhibitor for evaluation | 8 | 11,381 |
Replies
8
Views
11,381
|
10/21/2016 6:48:59 PM
by Mary Reid |
| Another suitable PARP-1 inhibitor for evaluation |
| Replies: 8 Views: 11,381 |
Latest: 10/21/2016 6:48:59 PM
by Mary Reid |
| ISRIB | 0 | 2,245 |
Replies
0
Views
2,245
|
9/28/2016 9:25:25 PM
by Dalerfink |
| ISRIB |
| Replies: 0 Views: 2,245 |
Latest: 9/28/2016 9:25:25 PM
by Dalerfink |
|
Guest |